Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Oragenics stock

Learn how to easily invest in Oragenics stock.

Oragenics is a biotechnology business based in the US. Oragenics shares (OGEN) are listed on the NYSE MKT and all prices are listed in US Dollars. Oragenics employs 5 staff and has a trailing 12-month revenue of around $218,508.

How to buy Oragenics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – OGEN. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Oragenics stock price (NYSE MKT: OGEN)

Use our graph to track the performance of OGEN stocks over time.

Oragenics shares at a glance

Information last updated 2023-01-23.
Latest market close$6.66
52-week range$6.04 - $27.21
50-day moving average $0.33
200-day moving average $0.31
Wall St. target price$1.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.14

Buy Oragenics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Oragenics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Oragenics price performance over time

Historical closes compared with the close of $6.66 from 2023-01-25

1 week (2023-01-19) 4,544.35%
1 month (2022-12-27) 5,023.08%
3 months (2022-10-27) 2,927.27%
6 months (2022-07-27) 1,918.18%
1 year (2022-01-27) 1,485.71%
2 years (2021-01-27) 617.67%
3 years (2020-01-27) 1,428.57%
5 years (2018-01-26) 146.67%

Oragenics financials

Revenue TTM $218,508
Gross profit TTM $-10,499,157
Return on assets TTM -44.32%
Return on equity TTM -77.73%
Profit margin 0%
Book value $0.10
Market capitalisation $270,135

TTM: trailing 12 months

Oragenics share dividends

We're not expecting Oragenics to pay a dividend over the next 12 months.

Have Oragenics's shares ever split?

Oragenics's shares were split on a 1:60 basis on 22 January 2023. So if you had owned 60 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Oragenics shares – just the quantity. However, indirectly, the new 5900% higher share price could have impacted the market appetite for Oragenics shares which in turn could have impacted Oragenics's share price.

Oragenics share price volatility

Over the last 12 months, Oragenics's shares have ranged in value from as little as $6.036 up to $27.21. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Oragenics's is 0.3889. This would suggest that Oragenics's shares are less volatile than average (for this exchange).

Oragenics overview

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc.

Frequently asked questions

What percentage of Oragenics is owned by insiders or institutions?
Currently 2.688% of Oragenics shares are held by insiders and 8.672% by institutions.
How many people work for Oragenics?
Latest data suggests 5 work at Oragenics.
When does the fiscal year end for Oragenics?
Oragenics's fiscal year ends in December.
Where is Oragenics based?
Oragenics's address is: 4902 Eisenhower Boulevard, Tampa, FL, United States, 33634
What is Oragenics's ISIN number?
Oragenics's international securities identification number is: US6840233026
What is Oragenics's CUSIP number?
Oragenics's Committee on Uniform Securities Identification Procedures number is: 684023104

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site